Patents by Inventor Shu-Ping Chen

Shu-Ping Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF ENHANCING AN IMMUNE RESPONSE
    Publication number: 20100080776
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Application
    Filed: February 11, 2008
    Publication date: April 1, 2010
    Applicant: Taplmmune, Inc.
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti
  • POLYMORPHIC FORM OF GRANISETRON HYDROCHLORIDE AND METHODS OF MAKING THE SAME
    Publication number: 20100048613
    Abstract: Crystalline granisetron hydrochloride characterized by a powder x-ray diffraction pattern with peaks at about 14.3, 20.4, and 23.0±0.2 degrees two-theta and process of making the same are disclosed.
    Type: Application
    Filed: August 18, 2009
    Publication date: February 25, 2010
    Inventors: Shu-Ping Chen, Hsiao-Ping Fang
  • Crystalline forms of docetaxel and process for preparation thereof
    Patent number: 7662980
    Abstract: Anbydrous crystalline form of docetaxel and process of making anhydrous docetaxel and docetaxel trihydrate are provided.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: February 16, 2010
    Assignee: Scinopharm Singapore PTE Ltd.
    Inventors: Yuan-Xiu Liao, Meng-Fen Ho, Shu-Ping Chen, Chia-Ning Lin, Yu-Li Lin, Tsung-Yu Hsiao
  • Crystalline Polymorphs of Gemcitabine Base
    Publication number: 20090326214
    Abstract: The present application provides several crystalline forms of gemcitabine base and methods of making the same.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 31, 2009
    Inventors: Shu-Ping Chen, Chia-Lin Charlene Shieh
  • Crystalline Forms of Docetaxel and process for Preparation Thereof
    Publication number: 20090275762
    Abstract: New anhydrous crystalline form of docetaxel and process of making anhydrous docetaxel and docetaxel trihydrate are provided.
    Type: Application
    Filed: July 13, 2009
    Publication date: November 5, 2009
    Inventors: Yuan-Xiu Liao, Meng-Fen Ho, Shu-Ping Chen, Chia-Ning Lin, Yu-Ll Lin, Tsung-Yu Hsiao
  • Method of crystallizing carvedilol phosphate and the product thereof
    Publication number: 20090076283
    Abstract: The present invention provides for a crystalline polymorph of Carvedilol phosphate salt and a process for making the same.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 19, 2009
    Applicant: ScinoPharm Taiwan Ltd.
    Inventors: Wen-Li Shih, Shu-Ping Chen
  • Levonorgestrel Crystallization
    Publication number: 20090069584
    Abstract: The present invention provides for a crystalline polymorph of levonorgestrel and processes for making the same.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 12, 2009
    Applicant: ScinoPharm Taiwan Ltd.
    Inventors: Yu-Sheng Chang, Shu-Ping Chen
  • Crystalline polymorph of exemestane
    Publication number: 20090018356
    Abstract: New crystalline polymorph of exemestane characterized by a powder X-ray diffraction pattern having peaks at 10.7±0.1, 15.9±0.1, and 18.1±0.1 2-theta degree.
    Type: Application
    Filed: June 24, 2008
    Publication date: January 15, 2009
    Applicant: ScinoPharm Taiwan Ltd.
    Inventors: WeiYu Chen, SinChi Wang, Shu-Ping Chen
  • Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
    Publication number: 20090012111
    Abstract: A crystalline polymorph of 7-ethyl-10-hydroxycamptothecin exhibiting an X-ray diffraction pattern having peaks at 10.9±0.2, 13.2±0.2, 23.9±0.2, and 26.1±0.2 2-theta degree.
    Type: Application
    Filed: June 24, 2008
    Publication date: January 8, 2009
    Applicant: ScinoPharm Taiwan Ltd.
    Inventors: Shu-Ping Chen, Piin-Jye Harn
  • Process for preparing aromatase inhibitors
    Publication number: 20080275259
    Abstract: A process of making an aromatase inhibitor of formula (I) wherein each of R1, R2, R3, and R4, independently, is hydrogen, halogen, or C1-C6 alkyl, comprising reacting a compound of formula (II) with an acid in the presence of a suitable solvent. A new crystalline form of exemestane and is also disclosed.
    Type: Application
    Filed: April 30, 2008
    Publication date: November 6, 2008
    Applicant: ScinoPharm Taiwan, Ltd
    Inventors: WeiYu Chen, Shu-Ping Chen
  • Crystalline forms of topotecan hydrochloride and processes for making the same
    Publication number: 20080269493
    Abstract: Novel crystalline forms of topotecan hydrochloride and processes of making the same are disclosed.
    Type: Application
    Filed: April 14, 2008
    Publication date: October 30, 2008
    Applicant: ScinoPharm Taiwan Ltd.
    Inventors: Tsung-Cheng Hu, Piin-Jye Harn, Shu-Ping Chen, Chia-Lin Charlene Shieh
  • Crystal forms of irinotecan hydrochloride
    Patent number: 7435818
    Abstract: The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.
    Type: Grant
    Filed: September 19, 2006
    Date of Patent: October 14, 2008
    Assignee: Scinopharm Taiwan, Ltd.
    Inventors: Shu-Ping Chen, Piin-Jye Harn
  • Method of enhancing an immune response
    Patent number: 7378087
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: May 27, 2008
    Assignee: TapImmune, Inc.
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti
  • Crystalline forms of docetaxel and process for preparation thereof
    Publication number: 20080108693
    Abstract: New anhydrous crystalline form of docetaxel and process of making anhydrous docetaxel and docetaxel trihydrate are provided.
    Type: Application
    Filed: October 19, 2007
    Publication date: May 8, 2008
    Applicant: Scinopharm Singapore PTE Ltd.
    Inventors: Yuan-Xiu Liao, Meng-Fen Ho, Shu-Ping Chen, Chia-Ning Lin, Yu-Li Lin, Tsung-Yu Hsiao
  • Novel crystal forms of irinotecan hydrochloride
    Publication number: 20070072890
    Abstract: The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.
    Type: Application
    Filed: September 19, 2006
    Publication date: March 29, 2007
    Applicant: ScinoPharm PTE, Ltd.
    Inventors: Shu-Ping Chen, Piin-Jye Harn
  • Laser ablation technique using in IC etching process
    Publication number: 20030136769
    Abstract: The present invention relates to a method of laser technology using in IC etching process, which uses by controlling the power of laser, repetition rate, timing of operation and modulation of laser beam's focus to apply in IC etching process to ablate the various materials on the surface of a wafer.
    Type: Application
    Filed: January 23, 2002
    Publication date: July 24, 2003
    Inventors: Yue-Yeh Lin, Shu-Ping Chen, Ya-Pai Yeh
  • Method of enhancing an immune response
    Publication number: 20030082195
    Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.
    Type: Application
    Filed: January 16, 2002
    Publication date: May 1, 2003
    Applicant: The University of British Columbia
    Inventors: Wilfred Arthur Jefferies, Qian-Jin Zhang, Susan Shu-Ping Chen, Judie Barbara Alimonti